BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function. The company was founded by Irit Arbel on September 22, 2000 and is headquartered in New York, NY.
Address
1325 AVENUE OF AMERICAS
NEW YORK, NY 10019
Founded
2000
Number of Employees
29
Website
http://www.brainstorm-cell.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)